Rules on remote prescribing, telehealth consultations, and digital health for cannabis.
Telemedicine has become a major patient-access channel for medical cannabis where remote prescribing is permitted. Rules differ sharply: some markets allow fully remote initial consultations and electronic narcotics prescriptions, while others require an in-person first visit — or prohibit remote prescribing of controlled substances entirely.
For platforms and clinics, the live compliance questions are prescription validity (e-script acceptance at pharmacies), cross-border recognition within the EU, and advertising restrictions on prescription-only medicines. Regulators in several markets are actively revising telehealth rules, which makes this one of the fastest-moving areas of cannabis regulation.